the Effect of Febuxostat on Coronary Plaque Volume in Patients With Chronic Stable Angina and Hyperuricemia
NCT02279342
·
clinicaltrials.gov ↗
PHASE4
Phase
TERMINATED
Status
1
Enrollment
OTHER
Sponsor class
Stopped
Entry were insufficient as expected.
Conditions
Coronary Artery Disease
Interventions
DRUG:
Febuxostat
Sponsor
Yokohama City University Medical Center